News

Published on 22 Mar 2024 on Zacks via Yahoo Finance

HOOKIPA Pharma Inc. (HOOK) Reports Q4 Loss, Tops Revenue Estimates


Article preview image

HOOKIPA Pharma Inc. (HOOK) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.20. This compares to loss of $0.17 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of 45%. A quarter ago, it was expected that this company would post a loss of $0.23 per share when it actually produced a loss of $0.17, delivering a surprise of 26.09%.

Over the last four quarters, the company has surpassed consensus EPS estimates two times.

NASDAQ.HOOK price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Why Is Penny Stock HOOKIPA Pharma Trading Higher On Wednesday?

Why Is Penny Stock HOOKIPA Pharma Trading Higher On Wednesday? Wednesday, HOOKIPA Pharma Inc (NAS...

Benzinga via Yahoo Finance 24 Apr 2024

Time To Worry? Analysts Just Downgraded Their HOOKIPA Pharma Inc. (NASDAQ:HOOK) Outlook

Today is shaping up negative for HOOKIPA Pharma Inc. (NASDAQ:HOOK) shareholders, with the analyst...

Simply Wall St. via Yahoo Finance 30 Mar 2024

HOOKIPA Pharma Inc. (HOOK) Reports Q4 Loss, Tops Revenue Estimates

HOOKIPA Pharma Inc. (HOOK) came out with a quarterly loss of $0.11 per share versus the Zacks Con...

Zacks via Yahoo Finance 22 Mar 2024

Strength Seen in Avidity Biosciences, Inc. (RNA): Can Its 15.0% Jump Turn into More Strength?

Avidity Biosciences, Inc. (RNA) shares ended the last trading session 15% higher at $12.04. The j...

Zacks via Yahoo Finance 29 Jan 2024

All You Need to Know About HOOKIPA Pharma Inc. (HOOK) Rating Upgrade to Strong...

HOOKIPA Pharma Inc. (HOOK) could be a solid choice for investors given its recent upgrade to a Za...

Zacks · via Yahoo Finance 16 Jan 2024

Some Analysts Just Cut Their HOOKIPA Pharma Inc. (NASDAQ:HOOK) Estimates

One thing we could say about the analysts on HOOKIPA Pharma Inc. (NASDAQ:HOOK) - they aren't opti...

Simply Wall St. via Yahoo Finance 15 Aug 2023

HOOKIPA Pharma Inc. (HOOK) Reports Q2 Loss, Lags Revenue Estimates

HOOKIPA Pharma Inc. (HOOK) came out with a quarterly loss of $0.22 per share versus the Zacks Con...

Zacks via Yahoo Finance 10 Aug 2023

Revenue Downgrade: Here's What Analysts Forecast For HOOKIPA Pharma Inc. (NASDAQ:HOOK)

Market forces rained on the parade of HOOKIPA Pharma Inc. (NASDAQ:HOOK) shareholders today, when ...

Simply Wall St. via Yahoo Finance 16 May 2023

HOOKIPA Pharma Inc. (HOOK) Reports Q1 Loss, Lags Revenue Estimates

HOOKIPA Pharma Inc. (HOOK) came out with a quarterly loss of $0.27 per share versus the Zacks Con...

Zacks via Yahoo Finance 11 May 2023

HOOKIPA Pharma Inc. (NASDAQ:HOOK) Q4 2022 Earnings Call Transcript

HOOKIPA Pharma Inc. (NASDAQ:HOOK) Q4 2022 Earnings Call Transcript March 15, 2023 Operator: Good ...

Insider Monkey via Yahoo Finance 18 Mar 2023